Perioperative management of upper tract urothelial carcinoma in the Nordic countries

dc.contributor.authorOedorf, Kimie
dc.contributor.authorHaug, Erik Skaaheim
dc.contributor.authorLiedberg, Fredrik
dc.contributor.authorJärvinen, Riikka
dc.contributor.authorGudjonsson, Sigurdur
dc.contributor.authorBoström, Peter J.
dc.contributor.authorJerlström, Tomas
dc.contributor.authorGudbrandsdottir, Gigja
dc.contributor.authorJensen, Jørgen Bjerggaard
dc.contributor.authorLam, Gitte Wrist
dc.contributor.organizationfi=kirurgia|en=Surgery|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.97295082107
dc.converis.publication-id457023399
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/457023399
dc.date.accessioned2025-08-28T00:52:43Z
dc.date.available2025-08-28T00:52:43Z
dc.description.abstract<p><strong>Background: </strong>Upper tract urothelial carcinoma (UTUC) is a rare malignancy, with typically only few new cases annually per urological department. Adherence to European association of urology (EAU) guidelines on UTUC in the Nordic countries is unknown. The objective of this survey was to examine the implementation of EAU guidelines, the perioperative management and organization of the treatment of UTUC in the Nordic countries.</p><p><strong>Methods: </strong>The electronic survey was distributed to 93 hospitals in the Nordic countries performing radical nephroureterectomy (NU). The survey consisted of 57 main questions and data was collected between December 1st, 2021 and April 23rd, 2022.</p><p><strong>Results: </strong>Overall response rate was 47/93 (67%) with a completion rate of 98%. Five out of the 6 examined subjects on diagnostic practice are applied by ≥ 72% of the participating centers. NU as treatment for high-risk UTUC is performed by 37/47 (79%), and 91% include a bladder cuff excision.</p><p><strong>Conclusions: </strong>Adherence to EAU guidelines is high on diagnostic practice in the Nordic countries, whereas disease management is less coherent.</p>
dc.identifier.eissn1471-2490
dc.identifier.jour-issn1471-2490
dc.identifier.olddbid206594
dc.identifier.oldhandle10024/189621
dc.identifier.urihttps://www.utupub.fi/handle/11111/48025
dc.identifier.urlhttps://bmcurol.biomedcentral.com/articles/10.1186/s12894-024-01515-7
dc.identifier.urnURN:NBN:fi-fe2025082791311
dc.language.isoen
dc.okm.affiliatedauthorBoström, Peter
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3126 Surgery, anesthesiology, intensive care, radiologyen_GB
dc.okm.discipline3126 Kirurgia, anestesiologia, tehohoito, radiologiafi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherBioMed Central
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.articlenumber132
dc.relation.doi10.1186/s12894-024-01515-7
dc.relation.ispartofjournalBMC Urology
dc.relation.issue1
dc.relation.volume24
dc.source.identifierhttps://www.utupub.fi/handle/10024/189621
dc.titlePerioperative management of upper tract urothelial carcinoma in the Nordic countries
dc.year.issued2024

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
s12894-024-01515-7.pdf
Size:
1.35 MB
Format:
Adobe Portable Document Format